Challenges facing colloidal delivery systems: From synthesis to the clinic
Authors:
- Angus P.R. JohnstonAJAngus P.R. Johnston
- Georgina K. SuchGeorgina K. Such
- Sher Leen NgSNSher Leen Ng
- Frank CarusoFCFrank Caruso
- 1 June 2011
- journal article
- review article
- Published by Elsevier in Current Opinion in Colloid & Interface Science
- Vol. 16 (3) , 171-181
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Acetal‐Modified Dextran Microparticles with Controlled Degradation Kinetics and Surface Functionality for Gene Delivery in Phagocytic and Non‐Phagocytic CellsAdvanced Materials, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- “Clickable” Polymer-Caged Nanobins as a Modular Drug Delivery PlatformJournal of the American Chemical Society, 2009
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- Top‐down particle fabrication: control of size and shape for diagnostic imaging and drug deliveryWIREs Nanomedicine and Nanobiotechnology, 2009
- Flexible Filaments for in Vivo Imaging and Delivery: Persistent Circulation of Filomicelles Opens the Dosage Window for Sustained Tumor ShrinkageMolecular Pharmaceutics, 2009
- The Pursuit of a Scalable Nanofabrication Platform for Use in Material and Life Science ApplicationsAccounts of Chemical Research, 2008
- Nanofabricated particles for engineered drug therapies: A preliminary biodistribution study of PRINT™ nanoparticlesJournal of Controlled Release, 2007
- Shape effects of filaments versus spherical particles in flow and drug deliveryNature Nanotechnology, 2007
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences, 2006